* Cryoport Inc CYRX.OQ CYRX.O is expected to show a rise
in
quarterly revenue when it reports results on November 3.
* The Brentwood Tennessee-based company is expected to
report a
23.4% increase in revenue to $69.955 million from $56.69 million
a year ago, according to the mean estimate from 9 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cryoport Inc is for
a
loss of 14 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 0.7%
in the last three months.
* Wall Street's median 12-month price target for Cryoport
Inc is
$49, above its last closing price of $27.86.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.16 -0.15 -0.23 Missed -52.2
Mar. 31 2022 -0.25 -0.20 -0.31 Missed -56.7
Dec. 31 2021 -0.16 -0.14 -0.11 Beat 20.8
Sep. 30 2021 -0.14 -0.14 -0.18 Missed -29.6
Jun. -0.12 -0.12 -0.16 Missed -32
30 2021
Mar. 31 2021 -0.18 -0.18 -0.13 Beat 28.8
Dec. 31 2020 -0.08 -0.11 -0.26 Missed -146
Sep. 30 2020 -0.13 -0.13 -0.29 Missed -128.9
This summary was machine generated November 2 at 01:10 GMT. All
figures in US dollars unless otherwise stated